NASDAQ:GENB | Cash Flow Statement | Generate Biomedicines, Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$67.26M
2026-03-31-$61.45M-$80.39M$3.78M-$259.93M$378.89M
2025-06-30-$52.43M
2025-03-31-$41.69M-$53.18M$751,000.00$75.53M$20.56M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow